|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:affects
|
euphoria
increased energy
enhanced sensory perception
increased empathy
emotional warmth
|
|
gptkbp:clinical_trial
|
gptkb:post-traumatic_stress_disorder
anxiety disorders
|
|
gptkbp:common_name
|
gptkb:Molly
Ecstasy
|
|
gptkbp:cultural_impact
|
music festivals
dance music
counterculture movements
|
|
gptkbp:environmental_impact
|
low
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MDMA
|
|
gptkbp:ingredients
|
C11 H15 N O2
|
|
gptkbp:is_popular_in
|
gptkb:psychologist
rave culture
clubbing
|
|
gptkbp:legal_issue
|
varies by country
|
|
gptkbp:lifespan
|
8 hours
|
|
gptkbp:manager
|
oral
injected
snorted
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:previous_name
|
3,4-methylenedioxymethamphetamine
|
|
gptkbp:related_concept
|
gptkb:amphetamine
gptkb:MDA
methamphetamine
MDEA
|
|
gptkbp:research_areas
|
gptkb:psychologist
neuroscience
addiction studies
|
|
gptkbp:safety_features
|
overheating
heart problems
kidney failure
serotonin syndrome
water intoxication
|
|
gptkbp:side_effect
|
anxiety
nausea
insomnia
dehydration
jaw clenching
|
|
gptkbp:symptoms
|
gptkb:historical_event
fatigue
irritability
difficulty concentrating
loss of appetite
|
|
gptkbp:tradition
|
can develop with repeated use
|
|
gptkbp:year_composed
|
gptkb:1970
|
|
gptkbp:year_created
|
1912
|
|
gptkbp:bfsParent
|
gptkb:Psychonaut
gptkb:Center_for_Psychedelic_and_Consciousness_Research
|
|
gptkbp:bfsLayer
|
5
|